Shpro (Mixture of Angelica Gigas and Astragalus Membranaceus) in Men with Lower Urinary Tract Symptoms: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

    January 2025 in “ Investigative and Clinical Urology ”
    Ji Hun Lee, Dahye Yoon, Geum Duck Park … Dae‐Young Lee
    Studysummary This study found that after 12 weeks of taking the trial product SHPro®, participants reported improvements in prostate symptom scores and erectile function, with confirmed safety.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on icurology.org →
    Discuss this study in the Community →

    Research cited in this study 3

    1. Risks And Side Effects In The Medical Management Of Benign Prostatic Hyperplasia Prostate International · 2023
    2. Finasteride and Erectile Dysfunction in Patients with Benign Prostatic Hyperplasia or Male Androgenetic Alopecia The World Journal of Men's Health · 2018
    3. The Clinical Development of a 5α-Reductase Inhibitor, Finasteride The Journal of Steroid Biochemistry and Molecular Biology · 1990